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Immunity to K1 Killer Toxin: Internal TOK1 Blockade
membrane. First, killer cells bind toxin normally to theirFederico Sesti, Theodore M. Shih,
Natalia Nikolaeva, and Steve A.N. Goldstein1 cell walls and remain immune even as cell wall-free
spheroplasts (Al-Aidroos and Bussey, 1978). Second,Departments of Pediatrics and Cellular
and Molecular Physiology killer resistant (kre) target cells commonly show resis-
tance due to diminished cell wall binding of toxin andBoyer Center for Molecular Medicine
Yale University School of Medicine yield toxin-sensitive spheroplasts (Boone et al., 1990).
Third, some kre mutants show normal cell wall binding295 Congress Avenue
New Haven, Connecticut 06536 of toxin and produce immune spheroplasts (Schmitt and
Compain, 1995). A model for immunity must also ac-
count for loss of both killing and immunity in strains
carrying mutant toxins with altered  chains (that medi-Summary
ate killing) or  chains (that affix preprotoxin to secretory
vesicle membranes to allow maturation) (Sturley et al.,K1 killer strains of Saccharomyces cerevisiae harbor
RNA viruses that mediate secretion of K1, a protein 1986; Zhu and Bussey, 1991). The most complete prior
model proposes that incompletely processed toxin trav-toxin that kills virus-free cells. Recently, external K1
toxin was shown to directly activate TOK1 channels els via the secretory pathway to the external membrane
surface where it remains tethered (by  chain) such thatin the plasma membranes of sensitive yeast cells,
leading to excess potassium flux and cell death. Here,  chain can directly compete with secreted toxin for
binding (Boone et al., 1986). However, this proposala mechanism by which killer cells resist their own toxin
is shown: internal toxin inhibits TOK1 channels and does not explain why membrane bound  chain does
not damage the cells, or address evidence that immunitysuppresses activation by external toxin.
proceeds from inside the cell. Thus, strains that process
toxin poorly (Wickner and Leibowitz, 1976) or expressIntroduction
nonsecreted toxins (such as those lacking the -leader
chain) (Lolle et al., 1984) accumulate internal toxinKiller strains of Saccharomyces cerevisiae carry RNA
viruses that direct secretion of peptide toxins lethal to (and/or precursors) and do not kill but retain at least
partial immunity. Study of TOK1 has now yielded a modelvirus-free cells, yet the killer cells themselves are im-
mune to the toxin they release (Boone et al., 1986; Bos- for immunity that accounts for all these observations.
We show here that K1 toxin acts directly on TOK1tian et al., 1980, 1984; Bussey, 1981). This favors envi-
ronmental dominance of virus-positive cells and is from inside the cell to suppress the effects of external
toxin. Thus, TOK1 is expressed in the plasma mem-significant in commercial fermentation and microbial
pathogenesis (Magliani et al., 1997; Starmer et al., 1992; branes of both immune and sensitive cells, but is acti-
vated by external toxin only in the sensitive cells. InWickner, 1996). K1 killer cells contain two double-
stranded viral components. The L-A component medi- the absence of external toxin, internal toxin is found
to reversibly inhibit TOK1. With external toxin present,ates viral transcription, replication, and encapsulation
and M1 encodes a  preprotoxin. Host en- internal toxin suppresses activation in a noncompetitive
fashion, that is, with no change in the half-maximal dos-zymes process the toxin precursor and cells release the
mature K1 toxin as an - heterodimer linked by three age for activation. Furthermore, an  chain toxin mutant
that does not kill spheroplasts but supports immunitydisulfide bonds (Bostian et al., 1984; Skipper et al., 1984;
Thiele and Leibowitz, 1982). Killing occurs by a two step does not activate TOK1 from the outside, but can block
the channel from the inside and suppress activation bymechanism: K1 first binds to 1-6--D-glucan receptors
on the yeast cell wall, a process controlled by the  external wild-type toxin. Thus, K1 toxin acts on TOK1
from opposite sides of the membrane to produce oppos-chain. The  chain then acts at the yeast cell plasma
membrane to produce unregulated potassium efflux and ing effects that correlate directly with the phenomena
of killing and immunity.cell death (Sturley et al., 1986; Zhu and Bussey, 1991).
We recently identified the TOK1 potassium channel as
a plasma membrane target for K1 toxin (Ahmed et al., Results
1999). Toxin activates TOK1 without a requirement for
other yeast or viral proteins to produce abnormal ion TOK1 Channels in Immune Cells Are Not Activated
flux. Overexpression of the TOK1 gene increases sensi- by External K1 Toxin
tivity to toxin while deletion confers resistance. K1 toxin produces a halo devoid of proliferating cells
How killer cells achieve immunity to the toxin they on lawns of virus-free target cells whether it is secreted
secrete has remained a mystery. It has long been known from virus-positive cells or isolated and allowed to dif-
that the single open reading frame for the  fuse from a filter disc (Figure 1A). As previously shown
preprotoxin is sufficient to confer both the ability to (Ahmed et al., 1999), external toxin applied to virus-free
kill and immunity (Bussey, 1991). Further, three findings target cells activates TOK1 channels leading to abnor-
have indicated that immunity takes place at the plasma mal potassium flux. This is demonstrated in Figure 1B
using whole-spheroplast voltage clamp configuration
and yeast cells overexpressing TOK1. In contrast, virus-1 Correspondence: steve.goldstein@yale.edu
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Figure 1. In Immune Yeast Cells, TOK1 Is Not Activated by External K1 Toxin
The K1 gene mediates immunity and inhibits activation of TOK1 channels by external toxin.
(A) Virus-free CY162C cells exposed to a streak of K12 killer cells or a filter disk with 15 l isolated K1 toxin (300 nM) on a YPD assay plate.
Plates were incubated at room temperature for 48 hr. Killing is seen as a halo in the lawn, resistance the absence of a halo.
(B) Spheroplasts from virus-free CY162 cells expressing pGKH-TOK1 studied in whole-cell configuration with or without 300 nM isolated
toxin in the solution. Voltage protocol: holding voltage 80 mV; 1 s steps from 80 to 60 mV in 10 mV increments; interpulse interval: 1 s.
(C) Virus-positive CY162 cells studied as in (A).
(D) Spheroplasts from virus-positive CY162 expressing pGKH-TOK1 studied as in (B).
(E) Virus-free CY162C cells expressing K1 toxin from pTx as in (A), but on YNB plates.
(F) Spheroplasts from virus-free CY162C cells expressing pGKH-TOK1 and pTx as in (B); scale bars represent 180 pA and 0.1 s.
positive target cells are immune, showing no halo zone analysis reveals that inhibition does not alter unitary
current magnitude (Figure 2C).(Figure 1C); moreover, TOK1 channels in these cells are
As it is experimentally difficult to expose the innerunresponsive to externally applied K1 toxin (Figure 1D).
surface of spheroplasts in stable fashion and TOK1 func-Thus, external toxin at 300 nM increases TOK1 cur-
tion in yeast cells and oocytes is similar (Ahmed et al.,rents in virus-free cells 1.8  0.1-fold but does not en-
1999), the latter were used to assess the attributes ofhance the current in virus-positive cells (1.1  0.1, n 
inhibition by internal toxin. A dose-inhibition relationship5). Notably, virus-free cells expressing K1 toxin from
for internal toxin reveals an inhibition constant (Ki) ofa plasmid demonstrate both immunity (Figure 1E) and
80  14 nM (n  5), a Hill coefficient of 1.3  0.1,suppression of activation by external toxin (Figure 1F,
without significant voltage dependence in the positive1.2  0.1-fold change, n  3). As expression of the gene
range (Figures 2C and 2D).for K1 toxin without other viral genes was sufficient to
Previously, we demonstrated that single TOK1 chan-confer immunity and counter activation of TOK1, we
nels open in bursts (periods when the channel movessought evidence that the toxin might interact directly
rapidly and repeatedly between the open state and twowith TOK1 from the cytoplasm.
short-lived closed states) interrupted by long-lasting
closures, sometimes lasting seconds. Here, we demon-
Internal Toxin Blocks TOK1 strate that in the absence or presence of internal toxin,
Excising inside-out patches from virus-free sphero- dwell time histograms again suggest three closed and
plasts exposes the cytoplasmic face of TOK1 channels one open state (Figures 2E and 2F). Internal toxin ap-
to the bath solution. K1 toxin applied in the bath inhibits pears to act primarily to stabilize the long interburst
TOK1 (Figure 2A) in a reversible fashion (Figure 2B, n  closed state (C3), increasing its duration over 4-fold (Ta-
7 patches). The same observation is made when toxin ble 1).
is applied to the inside of TOK1 channels expressed in
Xenopus oocytes, indicating that TOK1 is the only yeast Internal Toxin Suppresses Activation
cell protein required to produce reversible blockade by We next sought to study whether internal toxin in the
presence of external toxin could reproduce the behaviorinternal K1 toxin (n  8 patches); further single channel
Immunity to K1 Killer Toxin
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Figure 2. Internal Toxin Inhibits TOK1 Channels by Reverse Stabilization of the Long-Closed State
Internal toxin blocks TOK1 channels in patches excised from yeast cells or Xenopus laevis oocytes.
(A) Single TOK1 channel activity recorded in an inside-out patch excised from a virus-free CY162C spheroplast in the absence or presence
of 200 nM toxin as indicated. Holding voltage 	80 mV. Data filtered at 0.5 kHz, sampled at 2.5 kHz.
(B) A patch containing several TOK1 channels studied as in (A) with a holding voltage 	40 mV. Data filtered at 0.1 kHz, sampled at 0.5 kHz.
(C) TOK1 activity in inside-out patches excised from oocytes with various levels of applied internal K1 toxin as indicated. (Top) A multichannel
patch held at 80 mV and studied with 1 s steps from 80 to 60 mV; scale bar indicates 1.5 nA and 0.25 s. (Lower rows) A single TOK1 channel
at 	60 mV, unitary current was unchanged by toxin application (2.4  0.17 pA). For display, data filtered at 0.5 kHz, sampled at 2.5 kHz.
(D) Dose-response curve for blockade of macroscopic TOK1 currents in oocyte patches (as in [C, top]) fitted to the Hill function, H:
H 
1
1 	 ([toxin]/Kin)nH
with Kin 87  14 nM and nH  1.3  0.1 (n  5). Inset: voltage dependence of the blockage in the presence of 75 nM toxin.
(E) Single-channel activity recorded from an inside-out patch excised from an oocyte expressing TOK1 in the absence (upper trace) or presence
(lower trace) of 75 nM killer toxin for kinetic analysis. Holding voltage 	80 mV. For display, data were sampled at 0.3 kHz and filtered at 0.1 kHz.
(F) Representative histograms of the closed-state duration in the absence or presence of 75 nM killer toxin. Values reported in Table 1.
of TOK1 in immune cells. TOK1 channels in virus-free toxin, spheroplasts were loaded with controlled amounts
of internal toxin via the patch pipette and TOK1 activityspheroplasts that were first inhibited by internal toxin
could reversibly recover activity upon exposure to high evaluated with increasing concentrations of external
toxin (Figure 3B). Activation by external toxin was foundlevels of external toxin (Figure 3A). This was not associ-
ated with changes in the nonvoltage-dependent out- to be half-maximal at 30 nM in the absence and pres-
ence of internal toxin. Conversely, increasing levels ofward rectification of TOK1 channels (Figure 3A). To
quantify the opposing affects of internal and external internal toxin progressively limited the maximal re-
Table 1. Kinetic Parameters of TOK1 Channels in the Absence and Presence of Internal K1 Toxin

o (ms) 
C1 (ms) 
C2 (ms) 
C3 (ms) Oburst (ms) po
Control 0.9  0.5 1.3  0.2 13.3  2.5 383  143 31.1  4.5 0.17  0.07
75 nM Tx 1.1  0.7 1.6  0.3 18.3  3.5 1272  365 26.1  12.7 0.10  0.06
Dwell open (
o) and closed times (
C1, 
C2, 
C3), mean burst duration, and open probability of TOK1 channels held at 80 mV in inside-out patches
from oocytes in absence or presence of 75 nM internal toxin. Duration histograms were constructed with 20,000 to 50,000 events. Mean burst
duration was calculated according to [WC1/(1  WC1)][
C1 	 
o] 	 
o where WC1 indicates the weight of the fast component in the duration
histogram. For analysis, data filtered at 1 kHz and sampled at 5 kHz; all values are means  SEM for three patches.
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Figure 3. TOK1 Channels in Virus-Positive Cells or Virus-Free, Toxin-Loaded Cells Are Not Activated by External Toxin
(A) Single-channel recording with an outside-out patch from a virus-free CY162C spheroplast expressing pGKH-TOK1 with 110 nM toxin in
the pipette solution, in the absence or presence of 200 nM killer toxin in the bath, as indicated. Protocol: 1 s steps to 	60 and 60 mV
with a 1 s interpulse interval. In the absence of toxin, channel activity was observed in 5 of 55 traces. With external toxin, activity was observed
in 21 of 55 traces. Scale bars, 2.5 pA, 0.25 s.
(B) Dose-response relationship for external toxin at various levels of internal toxin using virus-free CY162C cells expressing pGKH-TOK1 at
	50 mV; cells were dialyzed with 30 (triangles), 75 (squares), and 110 nM toxin (circles) in the pipette and exposed to the indicated
levels of external toxin. Data fitted to a modified Hill function, H:
H  1 	
A
1 	 (Kout/[toxin])nH
and gave: Kout  27  13, nH  1.3  0.1 (n  3), Kout  28  11, nH  1.1  0.1 (n  3), and Kout  30  16, nH  1.2  0.3 (n  5), respectively.
(C) Dose-response relationships for external toxin using virus-positive CY162 cells (triangles) and virus-free CY162C cells (diamonds) in both
cases expressing pGKH-TOK1. Data fitted as in (B) and gave: Kout  30  18, nH  1.4  0.1 and Kout  28  8, nH 1.1  0.1 (n  5),
respectively. Native channels in CY162 and CY162C cells showed similar sensitivity: Kout  36  11, nH  1.1  0.1 and Kout  30  7, nH
1.3  0.1 (n  5 cells), respectively.
(D) Lineweaver-Burke type double reciprocal plot of the data in (B) and (C) using the same symbols. Extrapolated Kout 40 nM.
sponse to external toxin. Indeed, internal toxin sup- ates immunity should be unable to activate TOK1 from
the outside, but capable of suppressing activation bypressed TOK1 activation by external toxin so that the
external wild-type toxin. A toxin mutant carrying a fivecells were indistinguishable from those that were natu-
residue insertion (NPGLI) in the  chain at position 52rally resistant; the attributes of virus-positive cells and
has been reported to confer immunity but not killingvirus-free cells loaded with 75 to 110 nM internal K1
(Boone et al., 1986; Zhu and Bussey, 1991). When wetoxin were similar (Figures 3B and 3C). A double-recipro-
produced this toxin variant (Tx) and applied it to a lawncal analysis of the data (Figure 3D) supports the conclu-
of virus-free target cells, it did not produce a halo ofsion that varying levels of internal toxin did not alter the
growth inhibition (Figure 4A, left panel) as did wild-typeconcentration of external toxin required to achieve half-
toxin (Figure 1A). In keeping with expectations, externalmaximal activation (based on coincidence of dose-re-
Tx also did not activate TOK1 channels in virus-freesponse curves at the X intercept), but did alter its maxi-
spheroplasts (Figure 4B), even at levels up to 300 nMmal efficacy (curve slope). This is consistent with non-
(Figure 4C).competitive suppression of activation by internal toxin.
Conversely, virus-free cells expressing the mutant
toxin from a plasmid (pTx) were immune to wild-type
Tx, a Toxin Mutant that Confers Immunity toxin (Figure 5A), while cells expressing the empty plas-
and Blocks but Does Not Kill or Activate mid vector were killed (not shown). Furthermore, internal
These results suggest a model for immunity based on Tx inhibited TOK1 channels (Figure 5B), showing the
opposing actions of toxin on TOK1 that demands the same effectiveness as wild-type toxin (Figure 5C). In-
deed, internal Tx suppressed activation by externalfollowing correlation: a toxin that does not kill yet medi-
Immunity to K1 Killer Toxin
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Figure 4. Tx Does Not Kill or Activate TOK1
Insertion of five residues (NPGLI) in the  chain produces a mutant toxin that retains the immunity phenotype, but is ineffective in killing and
does not activate TOK1 channels.
(A) Virus-free CY162C cells exposed to a filter with 15 l isolated Tx (300 nM) on a YPD assay plate as in Figure 1A.
(B) Spheroplasts from virus-free CY162 cells expressing pGKH-TOK1 studied in whole-cell configuration in the absence (left) or presence
(right) of 300 nM Tx by the protocol in Figure 1B. Scale bars, 200 ms and 100 pA.
(C) Dose-response relationship for external Tx using virus-free CY162C cells expressing pGKH-TOK1 at 	50 mV. The solid curve is data
from Figure 3C for wild-type toxin.
wild-type toxin (Figure 5D) as potently as wild-type toxin to high resistance seal formation (Ahmed et al., 1999)
(Figure 5E). and tolerate overexpression of potassium channels (be-
cause they lack function of the potassium transporters
TRK1 and TRK2 and, so, require either supplementalNative and Overexpressed Wild-Type and Mutant
bath potassium or a potassium channel to grow [Ander-TOK1 Channels
son et al., 1992; Goldstein et al., 1996]). No qualitativeIn this study, both natural and plasmid-encoded TOK1
differences are apparent between naturally expressedchannels are evaluated, the latter to increase current
TOK1 in CY162 and plasmid-encoded channels. Thus,density and, so, macroscopic measurement precision.
CY162 cells are employed because they are amenable current density is depressed to a similar degree when
Figure 5. Tx Provides Immunity to Virus-Free Cells, Inhibits TOK1 Channels, and Suppresses Activation by External Wild-Type Toxin
(A) Virus-free CY162 cells expressing pTx exposed to a filter with 15 l of isolated wild-type toxin (300 nM) on a YNB assay plate as in
Figure 1A.
(B) Macroscopic TOK1 currents recorded from a giant inside-out patch excised from an oocyte in the absence (left) or presence (right) of
300 nM internal Tx (by the protocol in Figure 1B). Scale bars, 200 ms and 200 pA.
(C) Dose-response curves for internal Tx with TOK1 channels expressed in oocytes (as in [B]) calculated at 	50 mV. Data were fitted to the
Hill function as in Figure 2F, yielding Kin  56  12, nH  1.4  0.2 (n  5).
(D) Whole-cell current envelopes recorded from virus-free CY162C pGKH-TOK1 cells dialyzed with 110 nM Tx in the pipette, in the absence
(left) or presence (right) of 300 nM wild-type toxin by the protocol in Figure 1B. Scale bars, 200 ms and 50 pA.
(E) Dose-response relationship for external wild-type toxin at various levels of internal Tx using virus-free CY162C cells expressing pGKH-
TOK1 at 	50 mV as in Figure 3B; cells were dialyzed with 33 (circles) and 110 nM Tx (squares), respectively. Data fitted to a Hill function
H as in Figure 3B, and gave: Kout  38  13, nH  1.2  0.1 (n  3) and 38  7, nH  1.2  0.1 (n  5), respectively.
Cell
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Table 2. Native and Plasmid-Encoded TOK1 Current Density (pA/pF) and Effect of External K1 Toxin
Native TOK1 Overexpressed TOK1
Cell Type (Cells Studied) Basal K1 Basal K1
Virus-free (6) 13.8  4.7 29.0  9.9 218  70 415  133
Virus-positive (7) 5.9  1.6 6.5  1.8 123  40 148  48
Virus-free, pTX (4) 6.3  2.2 6.1  2.1 109  36 120  40
Virus-free, pTx (4) 5.9  1.9 6.5  2.1 135  35 128  33
Basal level of current in CY162C (virus-free) and CY162 (virus-positive) cells in the absence and presence of 300 nM external K1 toxin at
50 mV. Mean current densities (pA/pF, mean spheroplast capacitance was 2 pF). Unpaired student’s t test computed for each group of
cells (referred to virus-free) was 0.006  P  0.02. Values are means  SEM for the number of cells indicated.
virus-free and virus-positive cells are compared (Table associated with abnormal potassium flux, correlated
with cell death, and demonstrated no requirement for2). Further, external toxin fails to activate either native
or plasmid-encoded channels when the cells carried other yeast or viral proteins (Ahmed et al., 1999). This
report demonstrates that internal K1 toxin blocks TOK1virus or plasmids encoding wild-type or Tx K1 toxin
(Table 2). Finally, native and plasmid-encoded channels channels and suppresses activation by external toxin
(also without an apparent requirement for other proteins)show similar sensitivity to external K1 toxin (Figure 3C)
and indistinguishable killing and immunity behaviors in in a fashion that correlates with yeast cell immunity.
Moreover, a K1 mutant that confers immunity but doesthe halo assay (Figure 1).
Our conclusion that dysregulated TOK1 activity is suf- not kill blocks TOK1 from the inside, but does activate
the channel from the outside. These results support aficient to kill yeast cells (Ahmed et al., 1999) gains impor-
tant support from studies showing that galactose- model for killing and immunity of marvelous economy: a
single active principle that acts at two counterregulatoryinduced overexpression of TOK1 allows survival of trk1trk2
transport deficient SGY1529 cells in low (but not high) sites on one receptor; while secreted K1 activates TOK1
and kills, intracellular toxin suppresses activation andpotassium (Fairman et al., 1999), while overactive TOK1
mutants (for example, S330I and V456I channels) kill the produces resistance.
Single TOK1 channels open in bursts that are inter-cells (Loukin et al., 1997). As noted previously (Ahmed
et al., 1999), these mutant channels (studied in oocytes) rupted by long-lasting closures (Ahmed et al., 1999; Lou-
kin et al., 1997; Vergani et al., 1998). Previously, weare reported to show changes in closed-state stability
like those we observe when native TOK1 channels in found that external K1 toxin increased the duration and
frequency of open bursts without modifying unitary con-yeast cells are exposed to K1 toxin. Here, we show that
the lethal effect of S330I TOK1 channels is not strain, ductance or nonvoltage-dependent outward rectifica-
tion of the channels (Ahmed et al., 1999). Here, internalcarbon-source, nor killer phenotype specific. Thus,
MET25-induced overexpression of wild-type TOK1 con- toxin is seen to suppress activation in a noncompetitive
fashion via stabilization of the long interburst closedfers growth to CY162 and CY162C cells on plates with
7 mM potassium while induction of S330I TOK1 channels state (also without apparent changes in conductance
or rectification). That is, internal toxin does not diminishinhibits proliferation of both the virus-positive and virus-
free cells (not shown). In contrast to studies with the capacity of external toxin to produce half-maximal
current, but limits the maximum achievable current.SGY1529 (Fairman et al., 1999; Loukin et al., 1997),
CY162 and CY162C cells expressing V456I channels are These opposing effects of toxin from opposite sides of
the membrane are seen to correlate directly with expres-like those with wild-type TOK1, and overexpression of
wild-type TOK1 in the presence of 100 mM potassium sion of killing and immunity.
Like a noncompetitive inhibitor in an enzyme-sub-does not interfere with growth (Figure 1). Thus, constitu-
tive overexpression of wild-type TOK1 in CY162 and strate reaction, internal toxin combines with either free
channel or the channel-activator complex at a site otherCY162C cells is tolerated (Table 2), whereas induction
of S330I channels that are abnormally active due to the than that occupied by the activator (opposite sides of
the membrane) and, once bound, interferes with normalmutation, or exposure of wild-type channels to external
K1 toxin, blocks proliferation. function in a fashion that is not reversed by increasing
activator concentration. While it is feasible that the toxin
interacts with a single receptor site that is alternativelyDiscussion
exposed on opposite sides of the membrane, such a
conformational change makes it appropriate to treat theKiller strains impact yeast cell biology, the commercial
spirits industry, and biomedicine. Killer toxins also act sites as nonequivalent, in keeping with a noncompetitive
model.on nonyeast cells including bacteria, other molds, and
mammalian intestinal epithelia (Magliani et al., 1997; Pet- A model based on opposing effects of K1 toxin from
opposite sides of the membrane accounts for previoustoello-Mantovani et al., 1995). Recently, we showed that
external K1 toxin activates TOK1 (Ahmed et al., 1999), experimental evidence and reconciles a problem for ear-
lier proposals: toxin mutants whose function suggeststhe plasma membrane potassium channel of Saccharo-
myces cerevisiae (Ketchum et al., 1995; Zhou et al., immunity proceeds from inside the cell. Supporting the
idea that mature toxin is the species that acts from the1995) and does not form holes on its own as previously
suspected. Channel activation by external toxin was cytosol, both mature and precursor forms of wild-type
Immunity to K1 Killer Toxin
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and100-fold concentration and stored at20C. Control solutionstoxin are present at high levels inside killer cells (Bussey
were prepared boiling the isolated toxin for 30 min.et al., 1983; Lolle et al., 1984; Sturley et al., 1986), and
Killing and Immunity Assaystoxin mutants that are processed incompletely do not
CY162 and CY162C cells were grown overnight in 3 ml YPD with
confer wild-type levels of immunity when evaluated 100 mM KCl, diluted to OD600  0.1, and 0.1 ml spread to YPD (or
quantitatively (Boone et al., 1986). Moreover, there is YNB uracil-deficient plates) with 100 mM KCl, 0.03% methylene
blue, and 50 mM sodium citrate (pH 4.7). In some experiments, cellsample precedent for retrograde transport of mature se-
were transferred to plates with 7 mM KCl. Plates were incubated atcreted proteins into the cytoplasm. This pathway is the
room temperature for 48 hr after a single yeast colony was streakedprimary quality control mechanism for elimination of
across the lawn or a filter disk with toxin applied.misfolded proteins and is also employed to avoid aggre-
gation of abundant secretory proteins (Kjeldsen et al., Electrophysiology
1999; Plemper et al., 1999a). Since it does not require Spheroplasts
persistent contact with the translocation machinery, the Single colonies were grown overnight in 10 ml YPD media, har-
vested, and digested 40–50 min at 30C in 1 ml of a solution con-pathway permits bidirectional transport of fully pro-
taining: 400 U/ml Lyticase, 1 U/ml Chitinase, and 2000 U/mlcessed proteins (Plemper et al., 1999b). Indeed, the plant
-Glucuronidase (Sigma, MO), 1.2 M sorbitol, 50 mM K-phosphate/peptide ricin (Wesche et al., 1999) and bacterial Shiga
KOH buffer (pH 7.0), and 40 mM mercaptoethanol. Spheroplasts
toxin (Lord and Roberts, 1998) follow a similar reverse were enriched by layering the digested cells over a cushion (2 M
trajectory into the cytosol camouflaged as substrates sorbitol, 1 mM CaCl, 50 mM KH2PO4, 40 mM 2-mercaptoethanol [pH
of the protein degradation machinery. Thus, ricin is 7.0] with KOH), collected free of debris after centrifugation at 500
g for 5 min, and then washed and stored at 4C in: 250 mM KCl, 10transported retrograde through the Golgi apparatus to
mM CaCl, 5 mM MgCl, 5 mM HEPES, (pH 7.0) with KOH. As thethe endoplasmic reticulum where it is processed to liber-
same results were obtained in perforated-patch configuration andate the A-chain that then moves into the cytosol to inacti-
whole-cell mode, the latter was employed routinely as it was more
vate ribosomes and suppress protein synthesis. Of par- long lasting.
ticular note, another virally encoded S. cerevisiae toxin, Oocytes
K28, has been shown to enter and kill sensitive yeast Xenopus laevis oocytes were removed surgically, digested at room
temperature 30–60 min in Ringer solution and type 2 collagenasecells by traveling the secretory pathway in reverse to
(Worthington Biochemical Co.), and injected with 50 nl containingthe cytosol and then moving into the nucleus to block
10 ng TOK1 cRNA.DNA synthesis (Eisfeld et al., 2000). Work is now required
Data were recorded with an Axopatch 200B (Axon Instruments,
to establish the transport trajectory of K1 toxin, to deter- CA), a Quadra 800 Macintosh computer, and Pulse software (Heka,
mine if K1 precursors contribute to immunity when cells De) at filter and sampling frequencies of 0.5 kHz and 1.5 kHz, respec-
express a wild-type toxin gene, and to evaluate whether tively. Holding voltage was 80 mV. Voltage protocol for whole-cell
current envelopes consisted of 1 s pulses from 80 to 60 mV in 10the alternative pathway for killing and immunity revealed
mV increments spaced in 1 s interpulse intervals. For dose-responseby TOK1 deletion (Ahmed et al., 1999) operates in a
measurements, cells were also stimulated with trains of 11–25 con-similar fashion. More fundamentally, the natural role of
secutive 1 s voltage jumps from 80 to 50 mV that were averaged
TOK1 channels (and potassium ions) in yeast cell physi- online. Solutions for yeast spheroplasts: pipette solution contained,
ology remains to be elucidated. in mM: 175 KCl, 5 MgCl, 10 EGTA, 1 CaCl, 10 HEPES, (pH 7.0) with
KOH. Bath solution: 150 KCl, 10 CaCl, 5 MgCl, 10 HEPES, (pH 7.5)
with KOH. Solutions for oocytes: pipette and bath solution con-
Experimental Procedures tained, in mM: 150 KCl, 5 EGTA, 10 HEPES, (pH 7.5) with KOH.
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